Fondia Oyj (FONDIA.he) - Financial summary and valuation
Fondia Oyj

Company Overview

Fondia Oyj is a Finnish-based company that specializes in providing innovative legal services to its clients. As a leading provider of legal services, Fondia offers a range of products and services that cater to the evolving needs of its customers. With a strong focus on technology and innovation, Fondia has established itself as a pioneer in the field of legal services.

Fondia's primary mission is to provide high-quality legal services that meet the unique needs of its clients. The company's core values include a commitment to excellence, customer satisfaction, and continuous innovation. By embracing these values, Fondia aims to establish itself as a trusted partner for businesses and individuals seeking expert legal advice.

Key Products/Services

Fondia offers a range of key products and services that cater to the diverse needs of its clients. These include:

Fondia's products and services are designed to provide customers with a competitive edge in the market. By leveraging technology and innovation, Fondia aims to deliver high-quality legal services that meet the unique needs of its clients.

Benefits

The benefits of using Fondia's products and services include:

Fundamental to Fondia's success is its ability to innovate and adapt to the evolving needs of its customers. By embracing technology and innovation, Fondia has established itself as a leader in the field of legal services.



Valuation

2022 2023 2024 2025 2026 (e) 2027 (e) 2028 (e)
Number of Shares (million) 4.0 4.0 4.0 4.0 4.0 4.0 4.0
Target Valuation (MEur) 59.5 57.4 50.5 47.8 54.9 69.6 69.6
Targer Price 15.06 14.52 12.78 12.1 13.89 17.61 17.61
Potential, % 127.1 132.4 163.0 145.1 184.5 260.6 260.6
Recommendation Buy Buy Buy Buy Buy Buy Buy
MCAP (MEur) 26.2 24.7 19.2 19.5 19.3 19.3 19.3
Price 6.63 6.25 4.86 4.93 4.88 4.88 4.88
EV 21.0 21.0 17.0 19.0 17.0 15.0 13.0
P/S 1.06 0.95 0.75 0.82 0.78 0.73 0.68
EV/S 0.87 0.79 0.66 0.81 0.69 0.58 0.46
EV/EBIT 10.19 11.29 16.68 14.15 9.18 5.49 3.62
P/E 15.94 18.29 36.18 34.38 13.85 8.71 6.64
P/B 5.15 5.04 6.49 8.06 7.16 3.93 2.47
P/OCF 5.39 11.89 8.71 9763.91 4.98 6.76 6.28
EV/OCF 4.4 9.91 7.7 9733.61 4.44 5.36 4.28
P/FCF 6.87 31.44 15.57 -18.85 6.21 10.01 8.98
EV/FCF 5.61 26.21 13.76 -18.79 5.54 7.93 6.12

Income Statement

2022 2023 2024 2025 2026 (e) 2027 (e) 2028 (e)
Revenue 24.6 26.1 25.6 23.9 24.9 26.6 28.4
Rev. Growth, % 7.0 6.1 -1.9 -6.6 4.2 6.8 6.8
Ebit 2.1 1.8 1.0 1.4 1.9 2.8 3.6
Ebit Growth, % 10.5 -14.3 -44.4 40.0 35.7 47.4 28.6
Ebit, % 8.5 6.9 3.9 5.9 7.6 10.5 12.7
Profit 1.6 1.4 0.5 0.6 1.4 2.2 2.9
EPS 0.4 0.35 0.13 0.15 0.35 0.56 0.73
Profit Growth, % 14.3 -12.5 -64.3 20.0 133.3 57.1 31.8
Profit, % 6.5 5.4 2.0 2.5 5.6 8.3 10.2

Balance Sheet

2022 2023 2024 2025 2026 (e) 2027 (e) 2028 (e)
Inventory 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Acc. Receivable 2.6 2.6 2.5 3.3 2.5 2.7 2.9
Cash 4.8 4.1 2.2 0.3 1.8 3.7 5.9
Equity 5.1 4.9 3.0 2.4 2.7 4.9 7.8
ROE, % 31.4 28.6 16.7 25.0 51.9 44.9 37.2
ROCE, % 41.2 36.7 33.3 53.2 78.9 60.8 48.0
Net Debt -4.8 -4.1 -2.2 -0.1 -2.1 -4.0 -6.2
Gearing, % -94.1 -83.9 -75.8 -2.5 -76.7 -81.4 -78.6
Equity ratio, % 49.2 51.6 39.7 36.7 36.0 54.7 75.0
Acc. Payable 0.8 0.6 0.5 0.5 0.5 0.4 0.3
Total Assets 10.3 9.5 7.4 6.6 7.5 9.0 10.4
ROA, % 15.5 14.7 6.8 9.1 18.7 24.4 27.9

Cash Flow

2022 2023 2024 2025 2026 (e) 2027 (e) 2028 (e)
Operating Cash Flow 4.9 2.1 2.2 0.0 3.9 2.9 3.1
Investment Cash Flow -1.0 -1.3 -1.0 -1.0 -0.8 -0.9 -0.9
Free Cash Flow 3.8 0.8 1.2 -1.0 3.1 1.9 2.2
OCF/CAPEX 4.63 1.61 2.27 0.0 5.04 3.08 3.32
Financial Cash Flow -3.0 -2.8 -3.3 -0.9 -1.3 0.0 0.0




Fodelia Oyj Herantis Pharma Oyj









Disclaimer

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.

Before deciding to trade in financial instrument you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.

The data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Contact: quant@quantfactory.eu

About Us